id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-338647-dtuohsf5	Başcı, Semih	Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors	2020-08-27		.txt	text/plain	2709	169	55	INTRODUCTION: In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). METHOD: The data of 16 laboratory-confirmed COVID-19 patients with CML receiving TKI and age, gender, and comorbid disease matched COVID-19 patients without cancer at a 3/1 ratio (n = 48), diagnosed between March 11, 2020 and May 22, 2020 and included in the Republic of Turkey, Ministry of Health database, were analyzed retrospectively. RESULTS: The rates of intensive care unit (ICU) admission, and mechanical ventilation (MV) support were lower in CML patients compared to the control group, however, these differences did not achieve statistical significance (p = 0.1, and p = 0.2, respectively). Moreover, the rates of ICU admission and MV support, CFR were lower and length of hospital stay was shorter in CML patients receiving TKI compared to the age, gender and comorbidity matched control group but these differences were not statistically significant.	./cache/cord-338647-dtuohsf5.txt	./txt/cord-338647-dtuohsf5.txt